Modulation of allograft incorporation by continuous infusion of growth factors over a prolonged duration in vivo

Bone

Volumn 41, Issue 3, 2007, Pages 386-392

  Ma, Ting ^a   Gutnick, Jesse ^a   Salazar, Brent ^a   Larsen, Meegan D ^a   Suenaga, Eiji ^a   Zilber, Sebastien ^a   Huang, Zhinong ^a   Huddleston, James ^a   Smith, R Lane ^a   Goodman, Stuart ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft bone; Bone morphogenic protein 7; Fibroblast growth factor; Growth factors; Local infusion

Indexed keywords

ALKALINE PHOSPHATASE; CELL MARKER; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT OSTEOGENIC PROTEIN 1; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIREFRINGENCE; BONE ALLOGRAFT; BONE GRAFT; CANCELLOUS BONE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; EXPERIMENTAL MODEL; EXPERIMENTAL RABBIT; IN VIVO STUDY; MODULATION; MONOTHERAPY; NONHUMAN; OSSIFICATION; OSTEOCLAST; PROTEIN EXPRESSION; TIBIA; TREATMENT DURATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE TRANSPLANTATION; FIBROBLAST GROWTH FACTOR 2; GRAFT SURVIVAL; OSTEOGENESIS; RABBITS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547564474     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.05.015     Document Type: Article

References (31)

1. Gamradt S.C., and Lieberman J.R. Bone graft for revision hip arthroplasty: biology and future applications. Clin. Orthop. Relat. Res. 417 (2003) 183-194
2. Gazdag A.R., Lane J.M., Glaser D., and Forster R.A. Alternatives to autogenous bone graft: efficacy and indications. J. Am. Acad. Orthop. Surg. 3 1 (1995) 1-8
3. Leopold S.S., Jacobs J.J., and Rosenberg A.G. Cancellous allograft in revision total hip arthroplasty. A clinical review. Clin. Orthop. Relat. Res. 371 (2000) 86-97
4. Morgan H.D., McCallister W., Cho M.S., Casnellie M.T., and Leopold S.S. Impaction allografting for femoral component revision: clinical update. Clin. Orthop. Relat. Res. 420 (2004) 160-168
5. Lane J.M. Bone morphogenic protein science and studies. J. Orthop. Trauma 19 10 Suppl. (2005) S17-S22
6. Lamerigts N.M., Buma P., Aspenberg P., Schreurs B.W., and Slooff T.J. Role of growth factors in the incorporation of unloaded bone allografts in the goat. Clin. Orthop. Relat. Res. 368 (1999) 260-270
7. Thoren K., and Aspenberg P. Effects of basic fibroblast growth factor on bone allografts. A study using bone harvest chambers in rabbits. Ann. Chir. Gynaecol., Suppl. 207 (1993) 129-135
8. Wang J.S., and Aspenberg P. Basic fibroblast growth factor increases allograft incorporation. Bone chamber study in rats. Acta Orthop. Scand. 65 1 (1994) 27-31
9. Wang J.S., and Aspenberg P. Basic fibroblast growth factor enhances bone-graft incorporation: dose and time dependence in rats. J. Orthop. Res. 14 2 (1996) 316-323
10. Wang J.S., and Aspenberg P. Basic fibroblast growth factor infused at different times during bone graft incorporation. Titanium chamber study in rats. Acta Orthop. Scand. 67 3 (1996) 229-236
11. Jensen T.B., Overgaard S., Lind M., Rahbek O., Bunger C., and Soballe K. Osteogenic protein 1 device increases bone formation and bone graft resorption around cementless implants. Acta Orthop. Scand. 73 1 (2002) 31-39
12. Cook S.D., and Rueger D.C. Osteogenic protein-1: biology and applications. Clin. Orthop. Relat. Res. 324 (1996) 29-38
13. McGee M.A., Findlay D.M., Howie D.W., Carbone A., Ward P., Stamenkov R., et al. The use of OP-1 in femoral impaction grafting in a sheep model. J. Orthop. Res. 22 5 (2004) 1008-1015
14. Cook S.D., Barrack R.L., Santman M., Patron L.P., Salkeld S.L., and Whitecloud III T.S. The Otto Aufranc Award. Strut allograft healing to the femur with recombinant human osteogenic protein-1. Clin. Orthop. Relat. Res. 381 (2000) 47-57
15. Vonau R.I.B.M., Aspenberg P., and Sams A.E. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin. Orthop. Relat. Res. 386 (2001) 243-251
16. Hanada K., Dennis J.E., and Caplan A.I. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12 10 (1997) 1606-1614
17. Aspenberg P., Thorngren K.G., and Lohmander L.S. Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats. Acta Orthop. Scand. 62 5 (1991) 481-484
18. Ono I., Tateshita T., Takita H., and Kuboki Y. Promotion of the osteogenetic activity of recombinant human bone morphogenetic protein by basic fibroblast growth factor. J. Craniofac. Surg. 7 6 (1996) 418-425
19. Takita H., Tsuruga E., Ono I., and Kuboki Y. Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. Eur. J. Oral Sci. 105 6 (1997) 588-592
20. Ramoshebi L.N., and Ripamonti U. Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-beta1. Anat. Rec. 259 1 (2000) 97-107
21. Higashinakagawa M. Biological effects of basic fibroblast growth factor (bFGF) and osteogenic protein-1 (OP-1/BMP-7) on bone marrow cells and development of cell-hybrid artificial bone. Kokubyo Gakkai Zasshi 66 1 (1999) 118-130
22. Thompson T.J., Owens P.D., and Wilson D.J. Intramembranous osteogenesis and angiogenesis in the chick embryo. J. Anat. 166 (1989) 55-65
23. Thoren K., Aspenberg P., and Thorngren K.G. Lipid extraction decreases the specific immunologic response to bone allografts in rabbits. Acta Orthop. Scand. 64 1 (1993) 44-46
24. Aspenberg P., Albrektsson T., Lohmander L.S., and Thorngren K.G. Drug test chamber: a titanium implant for administration of biochemical agents to a standardized bone callus in situ. J. Biomed. Eng. 10 1 (1988) 70-73
25. Goodman S., Song Y., Chun L., Aspenberg P., Plouhar P., Glancy T., et al. Effects of local infusion of TGFbeta on bone ingrowth in rabbit chambers. J. Biomed. Mater. Res. 53 5 (2000) 475-479
26. Goodman S.B., Song Y., Yoo J.Y., Fox N., Trindade M.C., Kajiyama G., et al. Local infusion of FGF-2 enhances bone ingrowth in rabbit chambers in the presence of polyethylene particles. J. Biomed. Mater. Res., A 65 4 (2003) 454-461
27. Ma T., Nelson E.R., Mawatari T., Oh K.J., Larsen D.M., Smith R.L., et al. Effects of local infusion of OP-1 on particle-induced and NSAID-induced inhibition of bone ingrowth in vivo. J. Biomed. Mater. Res., A 79 3 (2006) 740-746
28. Goodman S.B. The effects of micromotion and particulate materials on tissue differentiation. Bone chamber studies in rabbits. Acta Orthop. Scand., Suppl. 258 (1994) 1-43
29. Yeh L.C., Tsai A.D., and Lee J.C. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J. Cell. Biochem. 87 3 (2002) 292-304
30. Traini T., Degidi M., Caputi S., Strocchi R., Di Iorio D., and Piattelli A. Collagen fiber orientation in human peri-implant bone around immediately loaded and unloaded titanium dental implants. J. Periodontol. 76 1 (2005) 83-89
31. Bromage T.G., Goldman H.M., McFarlin S.C., Warshaw J., Boyde A., and Riggs C.M. Circularly polarized light standards for investigations of collagen fiber orientation in bone. Anat. Rec. B New Anat. 274 1 (2003) 157-168